Skip to main content

Table 4 Presentation of patients with primary sclerosing cholangitis, their liver function tests on the last visit to the hospital and their outcomes

From: Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

Gender of PSC patient Age at diagnosis(years) Type of IBD AST (U/L) ALT (U/L) ALP (U/L) GGT (U/L) TBL (mg/dL) Duration PSC (years) Outcome
1.Male 32 CD 31 49 53 30 1 14 Slow progression
2.Male 48 UC 33 62 103 132 0.8 9 Slow progression
3.Female 51 CD 133 190 716 171 3.7 9 Before liver transplantation
4.Male 17 CD 14 19 50 33 0.7 1 Slow progression
5.Female 55 CD 41 56 43 15 0.9 19 Slow progression
6.Male 27 CD 18 15 61 21 0.9 5 Slow progression
7.Male 68 UC 97 58 92 41 0.7 12 Cirrhosis